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Introduction
Asthma is a chronic inflammatory condition of the airways
characterised by symptoms of reversible airflow
obstruction and bronchospasm. Despite recent advances
in the diagnosis and treatment, the prevalence of asthma
has increased in the last two decades, leading to
increased morbidity and utilisation of resources.1,2
According to the Centre for Disease Control and
Prevention (CDC), the proportion of people with asthma
has increased by 15% in the United States and accounts
for around $56 billion every year.3 Around 10% of the
world's population is currently suffering from asthma, 5%
of which is classified as severe disease.4 It is considered to
be a public health problem all over the world. However,
higher rates of mortality have been observed in low and
lower-middle income countries.2 This may be attributed
to multiple risk factors such as poor compliance, incorrect
perception of the use of inhalers, non-affordability of
medications, lack of follow-ups, non-availability of
healthcare facilities and overall lower socioeconomic
status and level of education.2,5,6
Acute severe asthma, previously known as status
asthmaticus, is defined as an asthma exacerbation which
is unresponsive to the conventional treatment with
bronchodilators and steroids, leading to respiratory
failure that can be potentially fatal.7,8 It accounts for one
of the most common causes of visits to the emergency
department (ED) and around one-fifth of all the episodes
managed in urgent care centres are considered to be
severe.7 Hence, failure to recognise the severity and delay
in treatment may lead to high rates of morbidity and
mortality. Patients with acute severe asthma may require
intensive care monitoring, mechanical ventilation and
prolonged hospitalisation, resulting in further economic
burden especially in developing countries. Furthermore,
these patients are at risk for developing serious and often
fatal complications, including asphyxia due to mucus
plugging, pneumo-thorax, pneumo-mediastinum,
pneumo-pericardium, cardiac arrhythmias, electrolyte
and metabolic disturbances and even myocardial
infarction (MI) and anoxic brain injury.7,9,10
Knowledge regarding predictors of morbidity and
mortality in these patients is, therefore, imperative in
making decisions regarding initial management,
treatment during hospital stay and follow-up. Although
much work has been done in assessing the clinical course
and outcomes of patients with acute severe asthma,
majority of the data available is from the Western
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Abstract
Objective: To evaluate the clinical course and outcomes in patients with acute severe asthma in a tertiary care
setting.
Methods: The retrospective cross-sectional study was conducted at the Aga Khan University Hospital, Karachi, and
comprised data of patients of age 16 and above who were admitted with a diagnosis of acute severe asthma from
January 2000 to December 2013.These patients had undergone clinical evaluation to assess the severity of illness as
well as the complications and eventual outcomes. SPSS 16 was used for statistical analysis.
Results: Of the 50 patients in the study, 41 (82%) were females. The overall mean age was 53.1±20.3 years. Ventilator
support was required by 37(74%) patients. Presence of acidaemia was associated with the need for invasive
ventilation (p<0.033) which in turn was associated with increased hospital stay (p<0.043). Complications were
observed in 37(74%) patients, the most common being respiratory failure in 35(70%) and arrhythmias in 8(16%). Use
of both non-invasive and invasive ventilation was found to be significantly associated with development of
complications (p<0.001and p<0.009). A total of 4(8%) patients died. Presence of acidaemia was found to be
significantly associated with mortality (p<0.032). 
Conclusion: Overt acidaemia at initial presentation in patients with acute severe asthma was significantly
associated with higher rates of invasive ventilation leading to increased hospital stay, complications and higher
mortality rate.
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population, while data from South Asia remains scarce.
The aim of this study was to review the clinical course,
prognostic factors, complications and outcomes in
patients with acute severe asthma in our setting.
Patients and Methods
The retrospective cross-sectional study was conducted at
the Aga Khan University Hospital (AKUH), Karachi, and
comprised patient data from January 2000 till December
2013. AKUH is a major tertiary care hospital serving more
than 10 million people of Karachi and the surrounding
region. With an operational strength of 650 beds, the
facility serves over 42,000 in-patients and over 500,000
out-patients annually. Established since 1985, it is one of
the few teaching hospitals in South Asia accredited with
the Joint Commission for International Accreditation.
The medical record numbers of patients are saved and
coded according to the diagnoses at the institution. After
obtaining approval from the institutional ethics
committee and in compliance with the International
Helsinki Declaration, data of all patients of age 16 years
and above who were admitted with the diagnosis of acute
severe asthma was extracted using the medical record
numbers. All the patients had been admitted either to a
'high dependency unit (HDU)' or an 'intensive care unit
(ICU)'.Patients who were less than 16 years of age or had
underlying lung diseases, including chronic obstructive
pulmonary disease (COPD), bronchiectasis and interstitial
lung disease (ILD), were excluded an so were patients who
had a history of smoking for more than 10 pack years.
The recorded data included demographics of the patients
including age, gender and co-morbid conditions, while
clinical parameters included patients' medications and
arterial blood gases (ABG) at the time of presentation, use
and type of mechanical ventilation, the course and length
of hospital stay, complications and eventual outcome of
the patient. Acute physiology and chronic health
evaluation (APACHE) II scores were calculated in order to
assess the severity of the illness.11
Statistical analysis was conducted using SPSS
16.Descriptive analysis was performed for demographic
and clinical characteristics and results were presented as
mean ± standard deviation (SD) for quantitative variables
and frequencies and percentages for qualitative variables.
The differences in baseline characteristics between
different groups were assessed by using the Chi-square
test or Fisher exact test where appropriate, whereas for
contrasts of continuous variables, independent sample t-
test was used to assess the difference of means. The p-
values were two sided and <0.05 was considered
statistically significant.
Results
Of the 50 patients in the study, 41(82%) were females. The
overall mean age was 53.1±20.3 years. The mean pH value
at the time of presentation was 7.33±0.11 (range: 6.96 -
7.56). Respiratory acidosis (pH<7.35) was observed in
22(44%) patients (Table-1).
Of the total, 37(74%) patients required ventilator support;
18(36%) required non-invasive ventilator support, while
19(38%) needed intubation. Five (10%) patients who were
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Table-1: Demographic and clinical characteristics of patients with acute severe asthma
(n=50).
Characteristics Number of patients (%)
Age in years (Mean ± S.D.) 53.1 ± 20.3
Gender
Male 9 (18%)
Female 41 (82%)
Underlying co-morbids
Hypertension 13 (26%)
Ischaemic heart disease 6 (12%)
Diabetes 5 (10%)
Chronic liver disease 1 (2%)
Stroke 1 (2%)
Others 5 (10%)
No co-morbids 22 (44%)
pH 7.33 ± 0.11
PaCO2 (mmHg) 52.9 ± 23.0
Length of hospital stay (days) 7.8 ± 5.8
Mean APACHE II score 9.36 ± 4.38
Medications
Inhaled SABA 17 (34%)
ICS + SABA 10 (20%)
ICS + LABA 10 (20%)
Oral Steroids 2 (4%)
Oral SABA 2 (4%)
Inhaled LABA 1 (2%)
Inhaled ipratropium 3 (6%)
Oral theophylline 2 (4%)
No treatment 5 (10%)
PaCO2: Partial pressure of carbon dioxideSABA: Short acting beta-agonist.
ICS: Inhaled corticosteroids.
LABA: Long acting beta agonist.
APACHE: Acute physiology and chronic health evaluation.
Table-2: Comparison between the duration of hospital stay and different types of
ventilatorsupport in patients with acute severe asthma (n=50).
Type of ventilator Number of Duration of hospital stay
support patients (%) in days (Mean±SD)
Non-invasive support 18 (36%) 7.2±4.4
Invasive mechanical support 19 (38%) 9.7±7.3
No ventilator support 13 (26%) 5.3±5.3
initially intubated required non-invasive ventilator
support following extubation. Presence of acidaemia was
significantly associated with the need for invasive
ventilation (p<0.033). The mean duration of hospital stay
was higher in patients who required ventilator support as
compared to those who did not (Table-2). Complications
were observed in 37 (74%) patients, the most common
being respiratory failure in 35(70%), arrhythmias in 8(16%)
and sepsis in 5(10%) patients, while pneumothorax
occurred in 1(2%) patient. The rate of development of
complications was higher in patients with a higher
APACHE II score (Table-3). 
Four (8%) patients died during the hospital stay; 2(4%)
because of sepsis, 1(2%) due to acute MI with resulting
cardiac arrest, and 1(2%) due to respiratory failure (Table-
4). Mean Partial pressure of carbon dioxide (PaCO2) was
significantly higher in non-survivors (p<0.044), while
although pH was lower in patients who did not survive,
this was not statistically significant (p<0.08).
The use of both non-invasive and invasive ventilator
support was significantly associated with developing
complications (p<0.0001 and p<0.009) while invasive
ventilator support was significantly associated with a
hospital stay of more than 7 days (p<0.032) (Table-5). 
Discussion
Asthma is a common disease and its incidence is expected
to rise in the next few decades. Although only 5% of the
asthmatics are considered to have severe disease, but
they account for almost 60% of the allotted budget to
asthma.4,12 To the best of our knowledge, this is the first
study to be reported on clinical outcomes of acute severe
asthma in our patient population.
In the current study, presence of acidaemia on initial
presentation was a significant predictor of poor
prognosis. It was associated with the need for intubation
and longer duration of hospital stay leading to
complications and mortality. Similar findings in patients
admitted to ICU with severe asthma have been observed
in the literature. A study reported a higher level of PaCO2
(63.8±21.3 vs 47.8±19.1mm Hg; p<0.01) and a lower pH
(7.09±0.12 vs 7.27±0.12; p<0.0001) in non-survivors
compared to the survivors9 while another study reported
hypercapnea to be an independent factor associated with
in-hospital mortality (Odds Ratio [OR]: 1.62; 95%
Confidence Interval [CI]: 1.37-1.91).13 Another study also
reported higher rate of mechanical ventilation
requirement in patients with lower arterial pH (p<0.001)
which was also related to a high mortality rate.14
Invasive mechanical ventilation was needed in 37%
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Table-3: Comparison between the rate of complications and APACHE II score in patients
with acute severe asthma (n=46).
APACHE II score Number of patients (%) Rate of complications (%)
0 - 4 7(14%) 3(43%)
5 - 9 21 (42%) 15 (71%)
10 - 14 15 (30%) 12 (80%)
>14 7 (14%) 7 (100%)
APACHE: Acute physiology and chronic health evaluation.
Table-4: Differences in baseline characteristics between survivors (n=46) and non-
survivors (n=4) in patients with acute severe asthma.
Characteristics Survivors Non-survivors p-value
Age in years (Mean ± S.D.) 52.3± 19.3 62± 32.2 0.366
Gender
Male 8 (17.4%) 1(25%) 0.560
Female 38 (82.6%) 3 (75%)
Mean APACHE score 9.1± 4.4 12.3± 3.3 0.098
Mean PaCO2 (mmHg) 51.3± 22.7 72.2± 20.0 0.044
Mean arterial pH 7.34± 0.11 7.24± 0.09 0.08
SD: Standard Deviation.
APACHE: Acute physiology and chronic health evaluation.
PaCO2: Partial pressure of carbon dioxide.
Table-5: Differences in clinical course and outcomes of patients receiving non-invasive and invasive ventilation (n=50).
Non-invasive ventilation Invasive ventilation
Yes No p-value Yes No p-value
Complications
Yes 22 (44%) 14 (28%) 0.001 18 (36%) 20 (40%) 0.006
No 1 11 (22%) 0 12 (24%)
Hospital stay
< 7 days 11 (22%) 18 (36%) N.S. 9 (18%) 23 (46%) 0.036
> 7 days 12 (24%) 7 (15%) 10 (20%) 8 (16%)
Outcome
Discharged 25 (50%) 22 (44%) N.S. 17 (34%) 30 (60%) N.S.
Death 1 (2%) 0 3 (6%) 0
patients while the mortality rate in the present study was
6.5% which is comparable to previously reported studies.
The in-hospital mortality for all asthmatics has been
reported to be around 1% to 5%15 while it varies widely
between 0% and 40% for patients with severe asthma
requiring mechanical ventilation.9,13-18 The wide variation
is most likely due to the differences in the level of
healthcare facilities, differences in approach by the
physicians over time and the fact that different patient
populations have been reported in these studies.
In our study, three of the non-survivors were females
whereas only one was male. Although this did not reach
statistical significance, but this was attributed to the small
sample size and majority of our patient population being
females. Female gender predilection in acute severe
asthma, however, has been reported in the past.9,13,18 This
might be due to a possibility that the pathogenesis of
severe asthma depends on gender-specific hormonal,
anatomical and biochemical factors.13,19 Furthermore,
differences in the perception of dyspnoea and severity
might also vary between the two genders with males
presenting later in the course of the disease as compared
to their female counterparts.20
The most common complications encountered in our
patients were respiratory failure, sepsis and arrhythmias.
Sepsis and acute respiratory distress syndrome (ARDS)
have been encountered as frequent complications in
patients admitted to the ICU with severe asthma.13,15
Furthermore, pneumothorax and non-pulmonary organ
failure are also not uncommon.13,15 However, the latter
were not encountered in our patients frequently.
Complications were more frequent in patients who
required mechanical ventilation possibly because it runs
the risk of causing barotrauma to the lung parenchyma.
Complications lead to increased duration of hospital stay
which in turn puts the patients at risk for developing
nosocomial infections and, hence, sepsis.
It is important to assess the severity of illness in order to
make appropriate decisions regarding therapeutic
management and determining the outcome of the
patient. APACHE II scores have been used to predict the
clinical outcome in patients admitted to the ICUs in the
past with higher scores predicting poorer prognosis.11
Earlier studies reinforced the utilisation of this score in
patients with severe asthma and reported increased
duration of hospital stay and high mortality rate with
higher APACHE II score.9,21 Although our results did not
reach statistical significance, mean APACHE II score was
found to be higher in non-survivors. Further prospective
studies from our setting would better assist in
determining the usefulness of this score in patients with
acute severe asthma.
There are several limitations of this study. Firstly, the
sample size was relatively smaller compared to previous
studies. However, this was inherent due to the stringent
inclusion criteria in which long-term smokers and patients
with COPD were excluded. Although this reduced the
sample size, the potential confounding factor of COPD as
discussed earlier13 was eliminated. Furthermore,
exclusion of these patients might also be a contributing
factor to a high proportion of females in this study since
smoking is more common in the males in our society.
Secondly, due to the retrospective nature of the study,
multiple risk factors such as level of education,
socioeconomic status, perception of medications and
prognostic factors such as ventilator parameters could
not be evaluated. Lastly, this was a single-centre study
and could not be generalised to the entire population.
Conclusion
Mortality related to acute severe asthma remains a
concern. Presence of overt acidaemia at initial
presentation is associated with a need for mechanical
ventilation which is in turn associated with a longer
duration of stay at the hospital and development of
complications. Presence of acidaemia also leads to a
poorer prognosis and higher mortality rate. However,
prospective studies with larger study populations are
needed to further validate the findings.
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